Viviana Chediack
A5061283928- Nosocomial Infections in ICU
- COVID-19 Clinical Research Studies
- Antibiotic Use and Resistance
- Pneumocystis jirovecii pneumonia detection and treatment
- Long-Term Effects of COVID-19
- Infection Control in Healthcare
- Clostridium difficile and Clostridium perfringens research
- Infectious Diseases and Mycology
- Public Health and Environmental Issues
- Mosquito-borne diseases and control
- Sepsis Diagnosis and Treatment
- Tuberculosis Research and Epidemiology
- Botulinum Toxin and Related Neurological Disorders
- Antifungal resistance and susceptibility
- Respiratory Support and Mechanisms
- Viral Infections and Vectors
- Urinary Tract Infections Management
- Antibiotic Resistance in Bacteria
- Streptococcal Infections and Treatments
- Diphtheria, Corynebacterium, and Tetanus
- Viral Infections and Outbreaks Research
- Actinomycetales infections and treatment
- Medical research and treatments
- COVID-19 and healthcare impacts
- Immunodeficiency and Autoimmune Disorders
Hospital Muñiz
2018-2025
Hospital El Cruce
2025
Instituto de Efectividad Clínica y Sanitaria
2025
Pontificia Universidad Javeriana
2019
Hospital Universitario San Ignacio
2019
Biology of Infection
2018
Engineering Associates (United States)
2018
Background Hyperbaric oxygen (HBO 2 ) therapy has been proposed to treat hypoxaemia and reduce inflammation in COVID-19. Our objective was analyse safety efficacy of HBO treatment patients with COVID-19 evaluate time correction. Methods This a multicentre, open-label randomised controlled trial conducted Buenos Aires, Argentina, between July November 2020. Patients severe (SpO ≤90% despite supplementation) were assigned receive either or the standard for respiratory symptoms 7 days. planned...
OBJECTIVE To analyze the impact of International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and INICC Surveillance Online System (ISOS) on central line-associated bloodstream infection (CLABSI) rates in 14 intensive care units (ICUs) Argentina from January 2014 to April 2017. DESIGN This prospective, pre-post surveillance study 3,940 ICU patients was conducted 11 hospitals 5 cities Argentina. During our baseline evaluation, we performed outcome process...
Introducción: los cuadros clínicos más graves y desenlaces fatales resultantes de la infección por SARS-CoV-2 han sido asociados con una hiperactivación del sistema inmune inmunotrombosis, proceso caracterizado respuesta inflamatoria exacerbada hipercoagulabilidad. Diferentes comorbilidades factores genéticos cada individuo podrían estar involucrados en un peor pronóstico. El objetivo este estudio fue analizar si distintos biomarcadores relacionados inflamación coagulación, así como ciertas...
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
Background: Coinfection with tuberculosis and COVID-19 has been shown to have a worse clinical course. Protective immunity is weakened in this situation, leading failure control both infections, reactivation of latent forms TB exacerbated progression active cases. Furthermore, corticosteroid therapy used the treatment severe infections can lead immunosuppression precipitate progression. Objectives: To describe characteristics, presentation evolution critically ill patients co-infection....
Background: HIV-infected patients (HIP) who ignore their HIV status or those without viral suppression, may develop Pneumocystis jirovecci pneumonia (PJP) and require admission to an intensive care unit (ICU), with a mortality rate of ICU PJP can still be up 60%. Our aims are describe clinical characteristics proven Aids-related determine factors related mortality. Methods & Materials: Among 1122 HIP admitted Infectious Diseases Hospital between 2006 2016, 63 had PJP. Clinical features,...
Background: The incidence, severity and mortality of Clostridium difficile infection (CDI) has been on the rise over last 20 year its estimated in 6-38%. Our aims are to determine clinical characteristics CDI factors related an intensive care unit (ICU). Methods & Materials: Among 1122 patients living with HIV admitted ICU between 2009 2016, 60 had CDI. Univariate analysis was performed identify death factors. Results expressed as percentage (%), median (Me), mean (M) range. A p value < 0.05...